160 related articles for article (PubMed ID: 22816442)
41. Drug-sensing hydrogels for the inducible release of biopharmaceuticals.
Ehrbar M; Schoenmakers R; Christen EH; Fussenegger M; Weber W
Nat Mater; 2008 Oct; 7(10):800-4. PubMed ID: 18690239
[TBL] [Abstract][Full Text] [Related]
42. Aptamer-functionalized hydrogels: An emerging class of biomaterials for protein delivery, cell capture, regenerative medicine, and molecular biosensing.
Abune L; Davis B; Wang Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1731. PubMed ID: 34132055
[TBL] [Abstract][Full Text] [Related]
43. An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease.
Xie B; Jin L; Luo Z; Yu J; Shi S; Zhang Z; Shen M; Chen H; Li X; Song Z
Int J Pharm; 2015 Jul; 490(1-2):375-83. PubMed ID: 26027491
[TBL] [Abstract][Full Text] [Related]
44. Controlled release of vascular endothelial growth factor from alginate hydrogels nano-coated with polyelectrolyte multilayer films.
Matsusaki M; Sakaguchi H; Serizawa T; Akashi M
J Biomater Sci Polym Ed; 2007; 18(6):775-83. PubMed ID: 17623557
[TBL] [Abstract][Full Text] [Related]
45. Biophysical characterization of VEGF-aHt DNA aptamer interactions.
Kanakaraj I; Chen WH; Poongavanam M; Dhamane S; Stagg LJ; Ladbury JE; Kourentzi K; Strych U; Willson RC
Int J Biol Macromol; 2013 Jun; 57():69-75. PubMed ID: 23470436
[TBL] [Abstract][Full Text] [Related]
46. Hyaluronic acid-based nanocomposite hydrogels for ocular drug delivery applications.
Widjaja LK; Bora M; Chan PN; Lipik V; Wong TT; Venkatraman SS
J Biomed Mater Res A; 2014 Sep; 102(9):3056-65. PubMed ID: 24124098
[TBL] [Abstract][Full Text] [Related]
47. Targeted and controlled release delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer-modified gold nanoparticles.
Danesh NM; Lavaee P; Ramezani M; Abnous K; Taghdisi SM
Int J Pharm; 2015 Jul; 489(1-2):311-7. PubMed ID: 25936625
[TBL] [Abstract][Full Text] [Related]
48. Diels-Alder hydrogels with enhanced stability: First step toward controlled release of bevacizumab.
Kirchhof S; Gregoritza M; Messmann V; Hammer N; Goepferich AM; Brandl FP
Eur J Pharm Biopharm; 2015 Oct; 96():217-25. PubMed ID: 26253504
[TBL] [Abstract][Full Text] [Related]
49. Self-Assembled Nanoconstructs Modified with Amplified Aptamers Inhibited Tumor Growth and Retinal Vascular Hyperpermeability via Vascular Endothelial Growth Factor Capturing.
Lee J; Lee BJ; Lee YM; Park H; Kim JH; Kim WJ
Mol Pharm; 2017 May; 14(5):1460-1468. PubMed ID: 28191845
[TBL] [Abstract][Full Text] [Related]
50. A novel electrochemiluminescence aptasensor for protein based on a sensitive N-(aminobutyl)-N-ethylisoluminol-functionalized gold nanoprobe.
Chai Y; Tian D; Gu J; Cui H
Analyst; 2011 Aug; 136(16):3244-51. PubMed ID: 21655607
[TBL] [Abstract][Full Text] [Related]
51. Engineering target-responsive hydrogels based on aptamer-target interactions.
Yang H; Liu H; Kang H; Tan W
J Am Chem Soc; 2008 May; 130(20):6320-1. PubMed ID: 18444626
[TBL] [Abstract][Full Text] [Related]
52. Fast functionalization of silver decahedral nanoparticles with aptamers for colorimetric detection of human platelet-derived growth factor-BB.
Li H; Zhu Y; Dong S; Qiang W; Sun L; Xu D
Anal Chim Acta; 2014 Jun; 829():48-53. PubMed ID: 24856402
[TBL] [Abstract][Full Text] [Related]
53. Reversible targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes.
Taghdisi SM; Lavaee P; Ramezani M; Abnous K
Eur J Pharm Biopharm; 2011 Feb; 77(2):200-6. PubMed ID: 21168488
[TBL] [Abstract][Full Text] [Related]
54. Aptamer-functionalized silver nanoparticles for scanometric detection of platelet-derived growth factor-BB.
Hu H; Li H; Zhao Y; Dong S; Li W; Qiang W; Xu D
Anal Chim Acta; 2014 Feb; 812():152-60. PubMed ID: 24491776
[TBL] [Abstract][Full Text] [Related]
55. Selection and characterization of DNA aptamers against VEGF165 with aptamer blotting method and its application.
Ikebukuro K; Hasegawa H; Sode K
Nucleic Acids Symp Ser (Oxf); 2007; (51):399-400. PubMed ID: 18029755
[TBL] [Abstract][Full Text] [Related]
56. Sequential delivery of TAT-HSP27 and VEGF using microsphere/hydrogel hybrid systems for therapeutic angiogenesis.
Shin SH; Lee J; Lim KS; Rhim T; Lee SK; Kim YH; Lee KY
J Control Release; 2013 Feb; 166(1):38-45. PubMed ID: 23262200
[TBL] [Abstract][Full Text] [Related]
57. Multifunctional interpenetrating polymer network hydrogels based on methacrylated alginate for the delivery of small molecule drugs and sustained release of protein.
Zhao J; Zhao X; Guo B; Ma PX
Biomacromolecules; 2014 Sep; 15(9):3246-52. PubMed ID: 25102223
[TBL] [Abstract][Full Text] [Related]
58. An aptamer-functionalized chemomechanically modulated biomolecule catch-and-release system.
Shastri A; McGregor LM; Liu Y; Harris V; Nan H; Mujica M; Vasquez Y; Bhattacharya A; Ma Y; Aizenberg M; Kuksenok O; Balazs AC; Aizenberg J; He X
Nat Chem; 2015 May; 7(5):447-54. PubMed ID: 25901824
[TBL] [Abstract][Full Text] [Related]
59. Silk fibroin/copolymer composite hydrogels for the controlled and sustained release of hydrophobic/hydrophilic drugs.
Zhong T; Jiang Z; Wang P; Bie S; Zhang F; Zuo B
Int J Pharm; 2015 Oct; 494(1):264-70. PubMed ID: 26283278
[TBL] [Abstract][Full Text] [Related]
60. Localized and sustained delivery of silencing RNA from macroscopic biopolymer hydrogels.
Krebs MD; Jeon O; Alsberg E
J Am Chem Soc; 2009 Jul; 131(26):9204-6. PubMed ID: 19530653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
